Efficacy of a microballoon catheter in transarterial chemoembolization of hepatocellular carcinoma using miriplatin, a lipophilic anticancer drug: Short-term results

Usefulness of Contrast-Enhanced Ultrasonography to Evaluate the Post-Treatment Responses of Radiofrequency Ablation for Hepatocellular Carcinoma: Comparison with Dynamic CT

(2013) Tatsuo Inoue et al.   ONCOLOGY

Phase I study of miriplatin combined with transarterial chemotherapy using CDDP powder in patients with hepatocellular carcinoma

(2012) Kenya Kamimura et al.   BMC GASTROENTEROLOGY

Warming Effect on Miriplatin–Lipiodol Suspension as a Chemotherapeutic Agent for Transarterial Chemoembolization for Hepatocellular Carcinoma: Preliminary Clinical Experience

(2012) Shinn-ichi Kora et al.   CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY

Dense Accumulation of Lipiodol Emulsion in Hepatocellular Carcinoma Nodule during Selective Balloon-occluded Transarterial Chemoembolization: Measurement of Balloon-occluded Arterial Stump Pressure

(2012) Toshiyuki Irie et al.   CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY

Guideline on the use of new anticancer drugs for the treatment of Hepatocellular Carcinoma 2010 update

(2012) Shuichi Kaneko et al.   HEPATOLOGY RESEARCH

Antitumor efficacy of transcatheter arterial chemoembolization with warmed miriplatin in hepatocellular carcinoma

(2012) Yuya Seko et al.   HEPATOLOGY RESEARCH

Current status of embolic agents for liver tumor embolization

(2012) Keigo Osuga et al.   International Journal of Clinical Oncology

Switching the Loaded Agent from Epirubicin to Cisplatin: Salvage Transcatheter Arterial Chemoembolization with Drug-eluting Microspheres for Unresectable Hepatocellular Carcinoma

(2011) Akihiko Seki et al.   CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY

A randomized phase II trial of intra-arterial chemotherapy using SM-11355 (Miriplatin) for hepatocellular carcinoma

(2011) Takuji Okusaka et al.   INVESTIGATIONAL NEW DRUGS

Transcatheter Arterial Chemotherapy Using Miriplatin-Lipiodol Suspension with or without Embolization for Unresectable Hepatocellular Carcinoma

(2011) N. Imai et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Usefulness of miriplatin as an anticancer agent for transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma

(2011) Yukinori Imai et al.   JOURNAL OF GASTROENTEROLOGY

Transcatheter Arterial Chemoembolization with Epirubicin-Loaded Superabsorbent Polymer Microspheres for 135 Hepatocellular Carcinoma Patients: Single-Center Experience

(2010) Akihiko Seki et al.   CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY

Intra-hepatic arterial administration with miriplatin suspended in an oily lymphographic agent inhibits the growth of tumors implanted in rat livers by inducing platinum-DNA adducts to form and massive apoptosis

(2008) Mitsuharu Hanada et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Intra-hepatic arterial administration with miriplatin suspended in an oily lymphographic agent inhibits the growth of human hepatoma cells orthotopically implanted in nude rats

(2008) Mitsuharu Hanada et al.   CANCER SCIENCE

Transarterial Chemoembolization for Hepatocellular Carcinoma with Drug-Eluting Microspheres: Preliminary Results from an Italian Multicentre Study

(2008) Maurizio Grosso et al.   CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY

Response Evaluation of Transcatheter Arterial Chemoembolization in Hepatocellular Carcinomas: The Usefulness of Sonazoid-Enhanced Harmonic Sonography

(2008) Yu Xia et al.   ONCOLOGY